DIBBS #SPE2DP-26-T-2504

DLA Procurement of Guaifenesin Extended-Release Tablets for Military Facilities

This procurement opportunity from the Defense Logistics Agency (DLA) seeks Guaifenesin Extended-Release pharmaceutical products for delivery to military facilities. - Government Buyer: - Defense Logistics Agency (DLA), DLA Troop Support Medical Supply Chain Pharm FSA - Contracting office at 700 Robbins Avenue, Philadelphia, PA - OEMs and Vendors: - AMERISOURCEBERGEN DRUG CORP (part number NDC46122-0683-74) - RB HEALTH US LLC (part number NDC63824-0023-35) - Products Requested: - Guaifenesin Extended-Release Tablets, NSN 6505-01-724-9533 - 1200mg, 14 tablets per blister pack, box of 1 blister pack - Two line items: 30 boxes and 25 boxes (total 55 boxes) - Only the listed OEMs are approved sources - Unique or Notable Requirements: - Delivery required within 5 days after award, with a target delivery date - Strict packaging, marking, and inspection requirements - Compliance with domestic sourcing laws and cybersecurity standards - No quantity variance allowed - Delivery Locations: - Fort Bragg, NC (5234 Eagle Talon Dr Bldg X3063) - Fort Stewart, GA (Bldg 1509 West 6th Street) - Other Details: - Fast award process - Not for children under 12 years; storage at 20-25°C (68-77°F)

Description

GUAIFENESIN EXTENDE (QTY: 25, NSN: 6505-01-724-9533, Purchase Request: 7016108788) Approved Sources: - CAGE: 1XUY5, Part No: NDC46122-0683-74, Company: AMERISOURCEBERGEN DRUG CORP - CAGE: 860J1, Part No: NDC63824-0023-35, Company: RB HEALTH US LLC

GUAIFENESIN EXTENDE (QTY: 30, NSN: 6505-01-724-9533, Purchase Request: 7016108772) Approved Sources: - CAGE: 1XUY5, Part No: NDC46122-0683-74, Company: AMERISOURCEBERGEN DRUG CORP - CAGE: 860J1, Part No: NDC63824-0023-35, Company: RB HEALTH US LLC

View original listing